Dallos, Tomáš [UKOLF1DK] - Heiland, Gisela Ruiz - Strehl, Johanna - Karonitsch, Thomas (3%) - Gross, Wolfgang L. - Moosig, Frank - Holl - Ulrich, Constanze - Distler, Jörg H. W. - Manger, Bernhard - Schett,Georg - Zwerina, Jochen : CCL17/thymus and activation-related chemokine in Churg-Strauss syndrome. Arthritis and Rheumatism. - Vol. 62, No. 11 (2010), s. 3496-3503. - ISSN 0004-3591

Dallos, Tomáš [UKOLF1DK] - Sahinbegovic, Enijad - Aigner, Elmar - Axmann, Roland - Schöniger-Hekele, Maximilian - Karonitsch, Thomas - Stamm, T. - Farkas, Martin - Karger, Thomas - Cavallaro, A. -Stölzel, Ulrich - Keysser, Gernot - Datz, Christian - Schett, Georg - Manger, Bernhard - Zwerina, Jochen: Validation ofradiographic scoring system for haemochromatosis arthropathy Annals of the Rheumatic Diseases. - Vol. 69, No. 12 (2010), s. 2145-2151. - ISSN 0003-4967

Prochotská, Katarína [UKOLF1DK] - Kovács, László [UKOLF] - Jankó, Viktor [UKOLF] - Dallos, Tomáš [UKOLF1DK] - Feber, Janusz : Association between obesity and the severity of ambulatory hypertension in children and adolescents.Journal of the American Society of Hypertension. - Vol. 6, No. 5 (2012), s. 356-363. - ISSN 1933-1711

Enijad Sahinbegovic, Tomáš Dallos, Elmar Aigner, Roland Axmann, Bernhard Manger, Matthias Englbrecht, Maximilian Schöniger‐Hekele, Thomas Karonitsch, Tanja Stamm, Martin Farkas, Thomas Karger, Ulrich Stölzel, Gernot Keysser, Christian Datz, Georg Schett, Jochen Zwerina. Musculoskeletal disease burden of hereditary hemochromatosis. Arthritis & Rheumatism 62 (12), 3792-3798

Pachydermodactyly: a review. T Dallos, B Oppl, L Kovács, J Zwerina Current Rheumatology Reports 16 (9), 1-7

Case report: Prader-Willi syndrome and inflammatory arthritis-an important consideration / Marelli, Luca [Autor, 11.112%] ; Dallos, Tomáš [Autor, UKOLF1DK, 11.111%] ; Miserocchi, Elisabetta [Korešpondenčný autor, 11.111%] ; Nucci, Paolo [Autor, 11.111%] ; Tombolini, Beatrice [Autor, 11.111%] ; De Lucia, Orazio [Autor, 11.111%] ; Gattinara, Maurizio [Autor, 11.111%] ; Caporali, Roberto [Autor, 11.111%] ; Marino, Achille [Autor, 11.111%] ; Jones, Jordan T. [Recenzent] ; Berard, Roberta Audrey [Recenzent]. – text. – [angličtina]. – [OV 180]. – [ŠO 5141]. – [článok]. – DOI 10.3389/fped.2023.1102382. – SIGN-UKO LF 1DK/23. – WOS CC ; SCO ; CCC In: Frontiers in pediatrics [elektronický dokument] . – Lausanne (Švajčiarsko) : Frontiers Media. – ISSN (online) 2296-2360. – Roč. 11, č. Marec (2023), art. no. 1102382, s. [1-10] [online] . – AIS: 0.702 ; CiteScore: 3,6 ; IF: 2.1 ; SJR: 0,715 ; SNIP: 0,891 AIS - Pediatrics - Q2 JCI - Pediatrics - Q2 JIF - Pediatrics - Q2 Scimago - Pediatrics, perinatology and child health - Q2

Is anti-NXP2 autoantibody a risk factor for calcinosis and poor outcome in juvenile dermatomyositis patients? : case series / Toplak, Natasa [Korešpondenčný autor, 11.112%] ; Pimpale Chavan, Pallavi [Autor, 11.111%] ; Rosina, Silvia [Autor, 11.111%] ; Dallos, Tomáš [Autor, UKOLF1DK, 11.111%] ; Rotem Semo, Oz [Autor, 11.111%] ; Aguiar, Cassyanne L. [Autor, 11.111%] ; Khubchandani, Raju [Autor, 11.111%] ; Ravelli, Angelo [Autor, 11.111%] ; Patwardhan, Anjali [Autor, 11.111%]. – text. – [angličtina]. – [OV 180]. – [ŠO 5141]. – [článok]. – [recenzované]. – DOI 10.3389/fped.2021.810785. – SIGN-UKO LF 1DK/22. – WOS CC ; SCO ; CCC In: Frontiers in pediatrics [elektronický dokument] . – Lausanne (Švajčiarsko) : Frontiers Media. – ISSN (online) 2296-2360. – Roč. 9, č. February (2022), art. no. 810785, s. [1-6] [online] . – IF: 2.6 ; SNIP: 1,087 ; SJR: 0,798 ; CiteScore: 3,3 ; AIS: 0.831 AIS - Pediatrics - Q2 JCI - Pediatrics - Q1 JIF - Pediatrics - Q2 Scimago - Pediatrics, perinatology and child health - Q1

Real-life vaccination coverage in Slovak children with rheumatic diseases / Balažiová, Barbora [Korešpondenčný autor, UKOLF1DK, 20%] ; Kuková, Zuzana [Autor, 20%] ; Mišíková, Dáša [Autor, 20%] ; Novosedlíková, Katarína [Autor, 20%] ; Dallos, Tomáš [Autor, UKOLF1DK, 20%]. – text. – [angličtina]. – [OV 180]. – [ŠO 5141]. – [článok]. – [recenzované]. – DOI 10.3389/fped.2022.956136. – SIGN-UKO LF 1DK/22. – WOS CC ; SCO ; CCC In: Frontiers in pediatrics [elektronický dokument] . – Lausanne (Švajčiarsko) : Frontiers Media. – ISSN (online) 2296-2360. – Roč. 10 (2022), art. no. 956136, s. [1-9] [online] . – IF: 2.6 ; SNIP: 1,087 ; SJR: 0,798 ; CiteScore: 3,3 ; AIS: 0.831 AIS - Pediatrics - Q2 JCI - Pediatrics - Q1 JIF - Pediatrics - Q2 Scimago - Pediatrics, perinatology and child health - Q1

Pyoderma gangrenosum-like ulceration as a presenting feature of pediatric granulomatosis with polyangiitis / Oz, Rotem Semo [Korešpondenčný autor, 20%] ; Onajin, Oluwakemi [Autor, 10%] ; Harel, Liora [Autor, 10%] ; Tal, Rotem [Autor, 10%] ; Dallos, Tomáš [Autor, UKOLF1DK, 10%] ; Rosenblatt, Adena [Autor, 10%] ; Plank, Lukáš [Autor, UKOLJ251, 10%] ; Wagner-Weiner, Linda [Autor, 20%]. – text, tab., obr. – [angličtina]. – [OV 180]. – [článok]. – DOI 10.1186/s12969-021-00564-8. – SIGN-UKO LJ224/21. – SIGN-UKO LF 1DK/21. – SCIE ; WOS CC ; SCO ; CCC In: Pediatric Rheumatology [elektronický dokument] . – Londýn (Veľká Británia) : Springer Nature. BioMed Central. – ISSN (online) 1546-0096. – Roč. 19, č. 1 (2021), Art. No. 81, s. 1-7] [online] . – CiteScore: 3,8 ; IF: 3.413 ; SJR: 0,711 ; SNIP: 1,284 ; AIS: 0.933 AIS - Pediatrics - Q2, Rheumatology - Q3 JIF - Pediatrics - Q2, Rheumatology - Q3 Scimago - Immunology and allergy - Q3, Pediatrics, perinatology and child health - Q2, Rheumatology - Q2

Happle-Tinschert, Curry-Jones and segmental basal cell naevus syndromes: overlapping disorders caused by somatic mutations in hedgehog-signalling genes - the mosaic Hedgehog spectrum / Lovgren, Marie-Louise [Korešpondenčný autor, 14.29%] ; Zhou, Y. [Autor, 14.285%] ; Hrčková, Gabriela [Autor, UKOLF1DK, 14.285%] ; Dallos, Tomáš [Autor, UKOLF1DK, 14.285%] ; Colmenero, I. [Autor, 14.285%] ; Twigg, S. R. F. [Autor, 14.285%] ; Moss, C. [Autor, 14.285%]. – text, fotogr., tab. – [angličtina]. – [OV 180]. – [článok]. – DOI 10.1111/bjd.18150. – SIGN-UKO LF 1DK/20. – WOS CC ; SCO ; CCC In: British Journal of Dermatology [textový dokument (print)] . – Hoboken (USA) : John Wiley & Sons. – ISSN 0007-0963. – ISSN (online) 1365-2133. – Roč. 182, č. 1 (2020), s. 212-217 [tlačená forma] . – IF: 9,302 ; SJR: 2,304 ; CiteScore: 11,6 ; SNIP: 2,367 ; AIS: 2.259 AIS - Dermatology - Q1 JIF - Dermatology - Q1 Scimago - Dermatology - Q1, Medicine (miscellaneous) - Q1

Enijad Sahinbegovic, Tomáš Dallos, Elmar Aigner, Roland Axmann, Bernhard Manger, Matthias Englbrecht, Maximilian Schöniger‐Hekele, Thomas Karonitsch, Tanja Stamm, Martin Farkas, Thomas Karger, Ulrich Stölzel, Gernot Keysser, Christian Datz, Georg Schett, Jochen Zwerina. Musculoskeletal disease burden of hereditary hemochromatosis. Arthritis & Rheumatism 62 (12), 3792-3798

Citation: Powell LW, Seckington RC, Deugnier Y. Haemochromatosis. Lancet. 2016 Aug 13;388(10045):706-16. doi: 10.1016/S0140-6736(15)01315-X. Epub 2016 Mar 12. PMID: 26975792.

Dallos, Tomáš [UKOLF1DK] - Heiland, Gisela Ruiz - Strehl, Johanna - Karonitsch, Thomas (3%) - Gross, Wolfgang L. - Moosig, Frank - Holl - Ulrich, Constanze - Distler, Jörg H. W. - Manger, Bernhard - Schett,Georg - Zwerina, Jochen : CCL17/thymus and activation-related chemokine in Churg-Strauss syndrome. Arthritis and Rheumatism. - Vol. 62, No. 11 (2010), s. 3496-3503. - ISSN 0004-3591

Citation: Monach PA, Warner RL, Tomasson G, Specks U, Stone JH, Ding L, Fervenza FC, Fessler BJ, Hoffman GS, Iklé D, Kallenberg CG, Krischer J, Langford CA, Mueller M, Seo P, St Clair EW, Spiera R, Tchao N, Ytterberg SR, Johnson KJ, Merkel PA. Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis. Ann Rheum Dis. 2013 Aug;72(8):1342-50. doi: 10.1136/annrheumdis-2012-201981. Epub 2012 Sep 12. PMID: 22975753; PMCID: PMC49824

Sahinbegovic E, Dallos T, Aigner E, Axmann R, Manger B, Englbrecht M, Schöniger-Hekele M, Karonitsch T, Stamm T, Farkas M, Karger T, Stölzel U, Keyßer G, Datz C, Schett G, Zwerina J. Musculoskeletal disease burden of hereditary hemochromatosis. Arthritis Rheum. 2010; 62(12): 3792-37988 IF 7,3

Citaion:Elmberg M, Hultcrantz R, Simard JF, Carlsson Å, Askling J. Increased risk of arthropathies and joint replacement surgery in patients with genetic hemochromatosis: a study of 3,531 patients and their 11,794 first-degree relatives. Arthritis Care Res (Hoboken). 2013 May;65(5):678-85. doi: 10.1002/acr.21883. PMID: 23139229.

Dallos T, Krivosíková M, Chorazy-Massalska M, Warnawin E, Zánová E, Rudnicka W, Radzikowska A, Maśliński W. BAFF from bone marrow-derived mesenchymal stromal cells of rheumatoid arthritis patients improves their B-cell viability-supporting properties. Folia Biol (Praha). 2009;55(5):166-76. PMID: 19863844.

Citation: Liu H, Li R, Liu T, Yang L, Yin G, Xie Q. Immunomodulatory Effects of Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Extracellular Vesicles in Rheumatoid Arthritis. Front Immunol. 2020 Aug 20;11:1912. doi: 10.3389/fimmu.2020.01912. PMID: 32973792; PMCID: PMC7468450.

Dallos T, Sahinbegovic E, Aigner E, Axmann R, Schöniger-Hekele M, Karonitsch T, Stamm T, Farkas M, Karger T, Cavallaro A, Stölzel U, Keysser G, Datz C, Schett G, Manger B, Zwerina J. Validation of a radiographic scoring system for haemochromatosis arthropathy. Ann Rheum Dis. 2010 Dec;69(12):2145-51. doi: 10.1136/ard.2009.122119. Epub 2010 Aug 2. PMID: 20679473.

Citation: Latourte A, Frazier A, Brière C, Ea HK, Richette P. Interleukin-1 receptor antagonist in refractory haemochromatosis-related arthritis of the hands. Ann Rheum Dis. 2013 May;72(5):783-4. doi: 10.1136/annrheumdis-2012-202738. Epub 2013 Jan 3. PMID: 23291388.

The role of natural immunity in the development and prognosis of juvenile idiopathic arthritis.

This is a basic science research project in cooperation with the Slovak Academy of Sciences. The project focuses on the role of natural immunity, neutrophils and neutrophil traps (NETs) in the initial (at manifestation) and advanced (at relapse) phase of JIA. The project is based on the hypothesis that neutrophils that are the dominant cell population in synovial effusion at the time of disease manifestation, generate NETs that may be an important factor in inflammation persistence and, consequently, a factor in disease relapse.

New classification of juvenile idiopathic arthritis (PRINTO project).

This study represents the clinical validation phase of a new classification of juvenile idiopathic arthritis (JIA) proposed by PRINTO (Paediatric Rheumatology International Trials Organisation) based on immunological (cytokine profile) and genetic markers. The aim of this prospective multicentre mutation study is to test and validate the new classification criteria in clinical practice. Our department is actively contributing to this study by enrolling patients with newly diagnosed JIA.

Immunization of children with rheumatic diseases on immunosuppressive therapy with a live attenuated measles, mumps and rubella (MMR) vaccine.

Vaccination with live attenuated vaccines is generally considered contraindicated in patients on ongoing immunosuppressive therapy. Our own data from Slovak patients suggest that such an approach interferes significantly with mandatory vaccination and puts these patients at disproportionately high risk of a severe course of measles at a time of increased measles incidence. The project reflects the position of the European League Against Rheumatism (EULAR), which allows MMR vaccination to be considered also in treated patients. This is a collaborative, multicentre, international, prospective study within the framework of the Paediatric Rheumatology European Society (PReS) Vaccination Working Group, in which our department is the largest contributor, so far.

Prognosis of patients with juvenile idiopathic arthritis (JIA)

JIA is a chronic disease, yet the goal of treatment is to achieve stable remission. Early diagnosis and adequately aggressive treatment allows some patients to achieve a state of long-term remission without treatment, while the probability of achieving remission may vary depending on both uncontrollable (JIA category, age, immunological profile, etc.) and controllable factors (timeliness of diagnosis, type and duration of immunosuppressive treatment). The aim of the project is to determine the real prognosis of JIA patients treated with currently available therapeutic modalities.

Identification and treatment of patients with rare immune-mediated diseases (IMID).

All paediatric rheumatic diseases fall into the category of rare diseases, but some ultra-rare diseases are also found among them, requiring challenging diagnostics, often beyond the capacity of local laboratories, and international collaboration to provide adequate treatment. Our aim is to create conditions for the diagnosis and treatment of patients with IMID, to accumulate experience with these diseases, and at the same time to contribute to the scientific and medical knowledge about these diseases by publishing their cases. We have established several international collaborations that allow us to better diagnose these diseases (Ljubljana - Slovenia, Budapest - Hungary, Leuven - Belgium, Hamburg and Freiburg - Germany, Prague - Czech Republic, Birmingham - USA). Our department has been accredited and obtained full membership in the European reference network RITA and is actively using its consultation paltform CPMS 2.0 to improve patient care. In this way, our department has managed to identify the first Slovak patients with familial Mediterranean fever (FMF), deficiency of adenosine deaminase 2 (DADA2), SITNG-associated vasculopathy with onset in childhood (SAVI) in recent years.